Jessica Garbern, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocytes, Cardiac | 6 | 2022 | 1589 | 1.950 |
Why?
|
Regenerative Medicine | 3 | 2022 | 293 | 1.500 |
Why?
|
Regeneration | 4 | 2022 | 1556 | 1.400 |
Why?
|
Pluripotent Stem Cells | 3 | 2021 | 809 | 1.090 |
Why?
|
Myocardium | 5 | 2022 | 5024 | 0.940 |
Why?
|
Growth Differentiation Factors | 2 | 2019 | 86 | 0.930 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2019 | 800 | 0.910 |
Why?
|
Induced Pluripotent Stem Cells | 3 | 2021 | 1532 | 0.910 |
Why?
|
Naphthyridines | 1 | 2019 | 124 | 0.760 |
Why?
|
Cardiomyopathies | 2 | 2020 | 1696 | 0.680 |
Why?
|
Bone Morphogenetic Proteins | 2 | 2019 | 885 | 0.640 |
Why?
|
Integrases | 1 | 2019 | 546 | 0.630 |
Why?
|
Stem Cell Transplantation | 3 | 2022 | 1660 | 0.610 |
Why?
|
Heart | 2 | 2022 | 4233 | 0.560 |
Why?
|
Myoblasts, Cardiac | 1 | 2013 | 23 | 0.530 |
Why?
|
Gene Deletion | 2 | 2019 | 2922 | 0.530 |
Why?
|
Heart Failure | 5 | 2020 | 9179 | 0.500 |
Why?
|
Acrylamides | 2 | 2010 | 233 | 0.470 |
Why?
|
Fibrosis | 1 | 2019 | 1798 | 0.470 |
Why?
|
Angiogenic Proteins | 1 | 2010 | 107 | 0.410 |
Why?
|
Myocarditis | 1 | 2015 | 622 | 0.400 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2019 | 2103 | 0.400 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2912 | 0.370 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2010 | 639 | 0.360 |
Why?
|
Heart Transplantation | 2 | 2020 | 2940 | 0.330 |
Why?
|
Hydrogels | 1 | 2010 | 629 | 0.290 |
Why?
|
Neovascularization, Physiologic | 2 | 2010 | 1447 | 0.280 |
Why?
|
Heart Diseases | 2 | 2013 | 2671 | 0.260 |
Why?
|
Toluene | 1 | 2019 | 40 | 0.210 |
Why?
|
Disease Models, Animal | 3 | 2019 | 18495 | 0.200 |
Why?
|
Benzothiazoles | 1 | 2019 | 252 | 0.180 |
Why?
|
Drug Delivery Systems | 1 | 2010 | 2297 | 0.180 |
Why?
|
Cell Differentiation | 3 | 2021 | 11833 | 0.180 |
Why?
|
Myosin Heavy Chains | 1 | 2019 | 398 | 0.170 |
Why?
|
Injections | 2 | 2010 | 894 | 0.170 |
Why?
|
Sirtuins | 1 | 2020 | 363 | 0.160 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2020 | 611 | 0.160 |
Why?
|
Nanomedicine | 1 | 2019 | 307 | 0.160 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2010 | 2729 | 0.150 |
Why?
|
Diffusion of Innovation | 1 | 2020 | 724 | 0.140 |
Why?
|
Embryo, Mammalian | 1 | 2021 | 1843 | 0.140 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 1761 | 0.130 |
Why?
|
Snakes | 1 | 2013 | 28 | 0.130 |
Why?
|
Amphibians | 1 | 2013 | 34 | 0.130 |
Why?
|
Animals | 10 | 2022 | 170849 | 0.120 |
Why?
|
Imidazoles | 1 | 2019 | 1288 | 0.120 |
Why?
|
Cell Line | 2 | 2019 | 17137 | 0.110 |
Why?
|
Waiting Lists | 1 | 2015 | 661 | 0.110 |
Why?
|
Ventricular Remodeling | 1 | 2019 | 1251 | 0.110 |
Why?
|
Forecasting | 1 | 2020 | 2956 | 0.100 |
Why?
|
Viscosity | 1 | 2010 | 313 | 0.100 |
Why?
|
Hematopoiesis | 1 | 2019 | 1961 | 0.100 |
Why?
|
Biotin | 1 | 2010 | 273 | 0.100 |
Why?
|
Myocardial Infarction | 1 | 2010 | 11266 | 0.100 |
Why?
|
Rats, Inbred F344 | 1 | 2010 | 897 | 0.100 |
Why?
|
Age Factors | 2 | 2019 | 19295 | 0.100 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2020 | 1978 | 0.100 |
Why?
|
Recovery of Function | 1 | 2020 | 2965 | 0.090 |
Why?
|
Mammals | 1 | 2013 | 688 | 0.090 |
Why?
|
Piperazines | 1 | 2019 | 2576 | 0.090 |
Why?
|
Systole | 1 | 2010 | 1008 | 0.090 |
Why?
|
Humans | 12 | 2022 | 686663 | 0.080 |
Why?
|
Mitochondria | 1 | 2021 | 3602 | 0.080 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 3076 | 0.080 |
Why?
|
Bone Marrow | 1 | 2017 | 2901 | 0.080 |
Why?
|
Graft Rejection | 1 | 2020 | 4314 | 0.080 |
Why?
|
Heart Ventricles | 1 | 2019 | 3857 | 0.080 |
Why?
|
Cyclic N-Oxides | 1 | 2005 | 89 | 0.070 |
Why?
|
Graft Survival | 1 | 2015 | 3766 | 0.070 |
Why?
|
Coronary Circulation | 1 | 2010 | 1662 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6970 | 0.070 |
Why?
|
Temperature | 1 | 2010 | 2135 | 0.070 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 12680 | 0.060 |
Why?
|
Mice, Knockout | 1 | 2019 | 15597 | 0.060 |
Why?
|
Disease Progression | 1 | 2019 | 13204 | 0.060 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2004 | 286 | 0.060 |
Why?
|
Zebrafish | 1 | 2013 | 2969 | 0.060 |
Why?
|
Phenotype | 1 | 2019 | 16091 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12734 | 0.050 |
Why?
|
Child | 3 | 2020 | 71361 | 0.050 |
Why?
|
Cells, Cultured | 2 | 2019 | 20620 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2020 | 6030 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12525 | 0.050 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 23439 | 0.050 |
Why?
|
Databases, Factual | 1 | 2015 | 7865 | 0.050 |
Why?
|
Computer Simulation | 1 | 2013 | 6120 | 0.050 |
Why?
|
Infant | 2 | 2020 | 33918 | 0.040 |
Why?
|
Rats | 3 | 2010 | 25307 | 0.040 |
Why?
|
Acetylation | 1 | 2020 | 1140 | 0.040 |
Why?
|
Ultrasonography | 1 | 2010 | 5876 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17071 | 0.040 |
Why?
|
Male | 7 | 2020 | 352465 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2020 | 15083 | 0.040 |
Why?
|
Child, Preschool | 2 | 2020 | 41159 | 0.040 |
Why?
|
Antioxidants | 1 | 2005 | 1699 | 0.040 |
Why?
|
NAD | 1 | 2020 | 587 | 0.040 |
Why?
|
Hepatocytes | 1 | 2004 | 1279 | 0.040 |
Why?
|
Mice | 3 | 2019 | 80803 | 0.040 |
Why?
|
Lysine | 1 | 2020 | 1036 | 0.040 |
Why?
|
Signal Transduction | 1 | 2019 | 24351 | 0.040 |
Why?
|
Risk Assessment | 1 | 2015 | 23739 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2020 | 3969 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2005 | 3190 | 0.030 |
Why?
|
Time Factors | 1 | 2015 | 42271 | 0.030 |
Why?
|
Risk Factors | 2 | 2020 | 69278 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2004 | 3429 | 0.030 |
Why?
|
Female | 4 | 2020 | 375459 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2020 | 67320 | 0.030 |
Why?
|
Adolescent | 2 | 2020 | 84957 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2020 | 4917 | 0.030 |
Why?
|
Inflammation | 1 | 2010 | 9617 | 0.030 |
Why?
|
Chromatin | 1 | 2020 | 2503 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2015 | 60991 | 0.020 |
Why?
|
Phosphorylation | 1 | 2020 | 8896 | 0.020 |
Why?
|
United States | 1 | 2015 | 65579 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2020 | 4461 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2020 | 3101 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6849 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2019 | 3457 | 0.020 |
Why?
|
Hypertension | 1 | 2005 | 7941 | 0.020 |
Why?
|
Rats, Inbred WKY | 1 | 2005 | 168 | 0.020 |
Why?
|
Rats, Inbred SHR | 1 | 2005 | 212 | 0.020 |
Why?
|
Drinking | 1 | 2005 | 198 | 0.020 |
Why?
|
Superoxides | 1 | 2005 | 411 | 0.020 |
Why?
|
Spin Labels | 1 | 2005 | 315 | 0.020 |
Why?
|
Models, Biological | 1 | 2020 | 10102 | 0.020 |
Why?
|
Microspheres | 1 | 2004 | 797 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 23953 | 0.010 |
Why?
|
Mice, SCID | 1 | 2004 | 2913 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39737 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 2923 | 0.010 |
Why?
|
Aorta | 1 | 2005 | 2133 | 0.010 |
Why?
|
Body Weight | 1 | 2005 | 4804 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 56052 | 0.010 |
Why?
|
Cell Survival | 1 | 2004 | 6288 | 0.010 |
Why?
|
Blood Pressure | 1 | 2005 | 8529 | 0.010 |
Why?
|